Diversified Healthcare Trust of Beneficial Interest (DHC) Financials
$8.01
As on 29-Sep-2026 13:36EDT
Market cap
$1,969 Mln
Revenue (TTM)
$1,500 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0.5 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
1,500.14
|
1,537.85
|
1,495.43
|
1,410.31
|
1,283.57
|
1,383.21
|
|||||
|
Cost of Revenue
|
1,578.86
|
1,783.19
|
1,239.05
|
1,185.00
|
1,109.07
|
1,091.81
|
|||||
|
Gross Profit
|
-78.73
|
-245.33
|
256.38
|
225.30
|
174.50
|
291.40
|
|||||
|
Operating Expenses
|
-47.57
|
-206.07
|
26.52
|
26.13
|
265.72
|
305.22
|
|||||
|
Operating Profit (EBIT)
|
-31.16
|
-39.27
|
229.86
|
199.17
|
-91.22
|
-13.82
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
313.80
|
468.27
|
|||||
|
Profit before Tax
|
-263.19
|
-284.14
|
-369.79
|
-293.13
|
-15.06
|
181.36
|
|||||
|
Provision for Tax
|
2.77
|
1.74
|
0.47
|
0.45
|
0.71
|
1.43
|
|||||
|
Profit after Tax (Net Income)
|
-265.96
|
-285.89
|
-370.26
|
-293.57
|
-15.77
|
174.52
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
-1.17
|
5.41
|
|||||
|
Consolidated Profit
|
--
|
--
|
--
|
--
|
-15.77
|
174.52
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,582.83
|
1,665.57
|
1,958.84
|
2,336.89
|
2,638.61
|
2,662.39
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
2,655.25
|
2,693.82
|
3,140.06
|
3,079.31
|
2,628.86
|
3,931.28
|
|||||
|
Current Liabilities
|
0.62
|
1.87
|
38.11
|
29.94
|
734.62
|
29.85
|
|||||
|
Total Liabilities
|
4,239.32
|
4,361.25
|
5,137.01
|
5,446.14
|
6,002.09
|
6,623.51
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
18.46
|
4,173.32
|
4,706.82
|
5,108.34
|
5,304.69
|
5,524.44
|
|||||
|
Current Assets
|
116.79
|
187.93
|
430.18
|
262.49
|
697.40
|
1,099.08
|
|||||
|
Total Assets
|
4,248.49
|
4,361.25
|
5,137.01
|
5,446.14
|
6,002.09
|
6,623.51
|
|||||
|
Total Debt*
|
2,417.93
|
2,417.94
|
2,910.90
|
2,816.85
|
3,078.05
|
3,680.88
|
|||||
|
Net Current Assets
|
107.00
|
92.05
|
392.08
|
232.55
|
-37.22
|
187.10
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-19.62
|
112.22
|
10.48
|
-40.35
|
-63.32
|
|||||
|
Cash Flow from Investing Activities
|
--
|
483.57
|
-187.02
|
-202.11
|
387.71
|
242.70
|
|||||
|
Cash from Financing Activities
|
--
|
-492.01
|
-22.31
|
-249.71
|
-676.00
|
746.72
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
-328.64
|
926.10
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-1.11
|
-1.19
|
-1.54
|
-1.23
|
-0.07
|
0.73
|
|||||
|
Cash EPS ($)
|
--
|
-0.10
|
-0.36
|
-0.13
|
0.94
|
1.87
|
|||||
|
Adjusted Book Value ($)
|
--
|
6.93
|
8.16
|
9.77
|
11.06
|
11.18
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-0.08
|
0.47
|
0.04
|
-0.17
|
-0.27
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-0.08
|
0.47
|
0.04
|
-0.17
|
-0.27
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-6.39
|
-7.39
|
-5.40
|
-0.26
|
2.73
|
|||||
|
ROE (%)
|
-16.37
|
-15.78
|
-17.24
|
-11.80
|
-0.60
|
6.61
|
|||||
|
ROA (%)
|
-5.96
|
-6.02
|
-7.00
|
-5.13
|
-0.25
|
2.66
|
|||||
|
EBIT Margin (%)
|
-3.30
|
-5.18
|
-3.68
|
-6.02
|
14.67
|
31.60
|
|||||
|
Net Margin (%)
|
-17.73
|
-18.59
|
-24.76
|
-20.82
|
-0.99
|
9.43
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-1.49
|
0.03
|
0.06
|
0.10
|
-0.07
|
-0.15
|
|||||
|
EBIT Growth (%)
|
37.37
|
-44.55
|
35.11
|
-145.10
|
-56.93
|
364.45
|
|||||
|
Net Profit Growth (%)
|
7.26
|
22.79
|
-26.12
|
-1,761.11
|
-109.04
|
225.14
|
|||||
|
EPS Growth (%)
|
7.47
|
0.23
|
-0.26
|
-17.56
|
-1.09
|
2.25
|
|||||
|
Book Value Growth (%)
|
-14.89
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-4.08
|
-1.49
|
-3.05
|
-9.78
|
4.22
|
|||||
|
Price / Book Value
|
1.25
|
0.70
|
0.28
|
0.38
|
0.06
|
0.28
|
|||||
|
Dividend Yield (%)
|
0.49
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
33.99
|
18.99
|
14.43
|
17.42
|
6.00
|
5.04
|
|||||
|
Close Price ($)
|
9.30
|
4.85
|
2.30
|
3.74
|
0.65
|
3.09
|
|||||
|
High Price ($)
|
9.66
|
5.16
|
4.24
|
3.96
|
3.45
|
5.58
|
|||||
|
Low Price ($)
|
3.18
|
2.00
|
2.13
|
0.63
|
0.61
|
2.35
|
|||||
|
Market Cap ($ Cr)
|
1,968.51
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.52
|
1.45
|
1.49
|
1.21
|
1.17
|
1.38
|
|||||
|
Short term debt to equity ratio
|
0.00
|
0.00
|
--
|
0.00
|
0.27
|
0.30
|
|||||
|
Current Ratio
|
188.99
|
100.72
|
11.29
|
8.77
|
0.95
|
36.83
|
|||||
|
Quick Ratio
|
188.99
|
--
|
--
|
--
|
0.96
|
-10.05
|
|||||
|
Interest Coverage
|
-0.20
|
-0.39
|
-0.23
|
-0.44
|
0.90
|
1.71
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
4.30
|
0.27
|
0.43
|
0.68
|
5.94
|
|||||
|
Asset Turnover
|
0.34
|
0.32
|
0.28
|
0.25
|
0.20
|
0.21
|
|||||
|
Receivable days
|
--
|
8.34
|
1.24
|
1.92
|
12.93
|
24.68
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
-2.69
|
228.94
|
253.24
|
|||||
|
Payable days
|
--
|
--
|
--
|
10.67
|
11.98
|
14.46
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
-11.44
|
229.89
|
263.46
|